Seminars in Hematology
Volume 41, Issue 4 , Pages 279-286 , October 2004

Gene therapy for the hemoglobin disorders

  • Derek A. Persons

      Affiliations

    • Department of Hematology/Oncology, Division of Experimental Hematology, St. Jude Children’s Research Hospital, Memphis, TN
    • Corresponding Author InformationAddress correspondence to Derek A. Persons, MD, PhD, Department of Hematology/Oncology, Division of Experimental Hematology, St. Jude Children’s Research Hospital, 332 N Lauderdale Dr, Memphis, TN 38105
    • ,
  • John F. Tisdale

      Affiliations

    • Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Disorders, National Institutes of Health, Bethesda, MD

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by the National Heart, Lung, and Blood Institute (NHLBI) Grants No. KO8 HL04205 and RO1 HL70705, NHLBI Comprehensive Sickle Cell Center Grant No. U54 HL70590, NHLBI Program Project Grant No. PO1 HL53749, Cancer Center Support (CORE) Grant No. CA-21765, and the American Lebanese Syrian Associated Charities.

PII: S0037-1963(04)00127-1

doi: 10.1053/j.seminhematol.2004.07.004

Seminars in Hematology
Volume 41, Issue 4 , Pages 279-286 , October 2004

Article Tools

* Image Usage & Resolution